Published in Mol Microbiol on March 01, 1999
Pathogenesis of group A streptococcal infections. Clin Microbiol Rev (2000) 15.35
M1 protein allows Group A streptococcal survival in phagocyte extracellular traps through cathelicidin inhibition. J Innate Immun (2009) 1.80
CD44 as a receptor for colonization of the pharynx by group A Streptococcus. J Clin Invest (2000) 1.30
The luxS gene of Streptococcus pyogenes regulates expression of genes that affect internalization by epithelial cells. Infect Immun (2003) 1.11
Role of group A streptococcal virulence factors in adherence to keratinocytes. Infect Immun (2000) 1.03
A nonpeptide integrin antagonist can inhibit epithelial cell ingestion of Streptococcus pyogenes by blocking formation of integrin alpha 5beta 1-fibronectin-M1 protein complexes. Proc Natl Acad Sci U S A (2000) 1.02
Role of CsrR, hyaluronic acid, and SpeB in the internalization of Streptococcus pyogenes M type 3 strain by epithelial cells. Infect Immun (2002) 0.87
M(+) group a streptococci are phagocytized and killed in whole blood by C5a-activated polymorphonuclear leukocytes. Infect Immun (2002) 0.81
Restoration of Mga function to a Streptococcus pyogenes strain (M Type 50) that is virulent in mice. Infect Immun (2001) 0.81
Complete Genome Sequences of emm6 Streptococcus pyogenes JRS4 and Parental Strain D471. Genome Announc (2015) 0.79
Hyaluronic acid capsule is a virulence factor for mucoid group A streptococci. Proc Natl Acad Sci U S A (1991) 3.60
Odorant-sensitive adenylate cyclase may mediate olfactory reception. Nature (1985) 2.94
Protein F1 is required for efficient entry of Streptococcus pyogenes into epithelial cells. J Infect Dis (1998) 2.49
Protein translocation into host epithelial cells by infecting enteropathogenic Escherichia coli. Mol Microbiol (1998) 2.17
Relative contributions of hyaluronic acid capsule and M protein to virulence in a mucoid strain of the group A Streptococcus. Infect Immun (1997) 2.13
The CD48 receptor mediates Staphylococcus aureus human and murine eosinophil activation. Clin Exp Allergy (2014) 1.98
Effects on virulence of mutations in a locus essential for hyaluronic acid capsule expression in group A streptococci. Infect Immun (1994) 1.92
Roles of integrins and fibronectin in the entry of Streptococcus pyogenes into cells via protein F1. Mol Microbiol (1998) 1.92
Bordetella pertussis invasive adenylate cyclase. Partial resolution and properties of its cellular penetration. J Biol Chem (1985) 1.78
Distribution of fibronectin-binding proteins among group A streptococci of different M types. J Infect Dis (1995) 1.77
Adherence and fibronectin binding are environmentally regulated in the group A streptococci. Mol Microbiol (1993) 1.66
Protein F: an adhesin of Streptococcus pyogenes binds fibronectin via two distinct domains. Mol Microbiol (1993) 1.65
A two-domain mechanism for group A streptococcal adherence through protein F to the extracellular matrix. EMBO J (1996) 1.54
A 49-residue peptide from adhesin F1 of Streptococcus pyogenes inhibits fibronectin matrix assembly. J Biol Chem (2001) 1.46
Adenylate cyclase activation by the beta-adrenergic receptors as a diffusion-controlled process. Biochemistry (1979) 1.42
Protein F2, a novel fibronectin-binding protein from Streptococcus pyogenes, possesses two binding domains. Mol Microbiol (1996) 1.40
Distinct steps in the penetration of adenylate cyclase toxin of Bordetella pertussis into sheep erythrocytes. Translocation of the toxin across the membrane. J Biol Chem (1992) 1.35
Requirements for cholera toxin-dependent ADP-ribosylation of the purified regulatory component of adenylate cyclase. J Biol Chem (1982) 1.33
Bordetella pertussis adenylate cyclase: purification and characterization of the toxic form of the enzyme. EMBO J (1989) 1.28
Agents that inhibit Rho, Rac, and Cdc42 do not block formation of actin pedestals in HeLa cells infected with enteropathogenic Escherichia coli. Infect Immun (1998) 1.24
Infections with Chryseomonas luteola (CDC group Ve-1) and flavimonas oryzihabitans (CDC group Ve-2). Medicine (Baltimore) (1995) 1.24
The regulatory component of adenylate cyclase. Purification and properties of the turkey erythrocyte protein. J Biol Chem (1981) 1.20
Characterization of a mouse-passaged, highly encapsulated variant of group A streptococcus in in vitro and in vivo studies. J Infect Dis (2000) 1.17
De novo formation of focal complex-like structures in host cells by invading Streptococci. Mol Microbiol (2001) 1.15
Islet-activating protein blocks glucagon desensitization in intact hepatocytes. Biochem J (1984) 1.13
Specific interactions between F1 adhesin of Streptococcus pyogenes and N-terminal modules of fibronectin. J Biol Chem (2001) 1.09
Bordetella pertussis adenylate cyclase. Identification of multiple forms of the enzyme by antibodies. J Biol Chem (1988) 1.09
Mode of coupling between hormone receptors and adenylate cyclase elucidated by modulation of membrane fluidity. Nature (1978) 1.07
Adenylate cyclase toxin from Bordetella pertussis. The relationship between induction of cAMP and hemolysis. J Biol Chem (1991) 1.06
Invasive adenylate cyclase toxin of Bordetella pertussis. Trends Biochem Sci (1989) 1.05
Streptococcus pyogenes protein F promotes invasion of HeLa cells. Microbiology (1998) 1.04
The invasive adenylate cyclase of Bordetella pertussis. Intracellular localization and kinetics of penetration into various cells. Biochem J (1987) 1.01
Cloning of the adenylate cyclase genetic determinant of Bordetella pertussis and its expression in Escherichia coli and B. pertussis. Microb Pathog (1988) 1.01
The invasive adenylate cyclase of Bordetella pertussis. Properties and penetration kinetics. Biochem J (1987) 1.00
Ongoing epidemic of Mycoplasma pneumoniae infection in Jerusalem, Israel, 2010 to 2012. Euro Surveill (2012) 1.00
Bordetella pertussis adenylate cyclase toxin: intoxication of host cells by bacterial invasion. Infect Immun (1990) 0.98
A matrix form of fibronectin mediates enhanced binding of Streptococcus pyogenes to host tissue. J Biol Chem (1997) 0.97
The action of islet activating protein (pertussis toxin) on insulin's ability to inhibit adenylate cyclase and activate cyclic AMP phosphodiesterases in hepatocytes. Biochem J (1986) 0.95
Characterization of the C-terminal domain essential for toxic activity of adenylate cyclase toxin. Mol Microbiol (1999) 0.93
Invasive pneumococcal infections. A comparison between adults and children. Medicine (Baltimore) (1997) 0.92
Culture-based methods for detection and identification of Streptococcus agalactiae in pregnant women--what are we missing? Eur J Clin Microbiol Infect Dis (2007) 0.90
Antibodies to Bordetella pertussis adenylate cyclase are produced in man during pertussis infection and after vaccination. J Med Microbiol (1990) 0.90
Puerperal and intrapartum group A streptococcal infection. Infect Dis Obstet Gynecol (1999) 0.90
The guanine nucleotide-binding regulatory component of adenylate cyclase in human erythrocytes. J Cyclic Nucleotide Res (1982) 0.89
Bacterial pneumonia in recipients of bone marrow transplantation. A five-year prospective study. Transplantation (1995) 0.89
Maintenance of meiotic arrest in isolated rat oocytes by the invasive adenylate cyclase of Bordetella pertussis. Biol Reprod (1987) 0.88
Temperature dependence of beta receptor, adenosine receptor, and sodium fluoride stimulated adenylate cyclase from turkey erythrocytes. Biochemistry (1980) 0.87
Activation of adenylate cyclase by sperm membranes. The role of guanine nucleotide binding proteins. FEBS Lett (1983) 0.86
Bordetella pertussis adenylate cyclase inactivation by the host cell. Biochem J (1989) 0.86
Ethical issues relating to the use of antimicrobial therapy in older adults. Clin Infect Dis (2001) 0.84
A retrospective six-year national survey of P. multocida infections in Israel. Scand J Infect Dis (2009) 0.83
Déjà vu: Ralstonia mannitolilytica infection associated with a humidifying respiratory therapy device, Israel, June to July 2011. Euro Surveill (2013) 0.82
Proteins M6 and F1 are required for efficient invasion of group A streptococci into cultured epithelial cells. Adv Exp Med Biol (1997) 0.82
Regulation of host cell recognition in Streptococcus pyogenes. Dev Biol Stand (1995) 0.82
Hepatitis B virus infection among blood donors and pregnant women in Maiduguri, Nigeria. East Afr Med J (1994) 0.82
Spontaneous phase variation in Bordetella pertussis is a multistep non-random process. EMBO J (1984) 0.82
The allosteric inhibition by calcium of soluble and partially purified adenylate cyclase from turkey erythrocytes. Eur J Biochem (1977) 0.81
Studies on phase variation in Bordetella pertussis. Dev Biol Stand (1985) 0.80
Increasing risk of transfusion-associated AIDS as the pandemic spreads: experience in Maiduguri, Nigeria. J Trop Med Hyg (1993) 0.80
Streptococcus pyogenes emm and T types within a decade, 1996-2005: implications for epidemiology and future vaccines. Epidemiol Infect (2009) 0.80
Exposure to ertapenem is possibly associated with Pseudomonas aeruginosa antibiotic resistance. Clin Microbiol Infect (2013) 0.78
The absence of desensitization in the beta adrenergic receptors of turkey reticulocytes and erythrocytes and its possible origin. Life Sci (1978) 0.78
Construction of mini-Tn5cyaA' and its utilization for the identification of genes encoding surface-exposed and secreted proteins in Bordetella bronchiseptica. FEMS Microbiol Lett (2001) 0.78
Purification and properties of the regulatory component (G/F) of adenylate cyclase. Adv Cyclic Nucleotide Res (1981) 0.77
Necrotizing fasciitis: flesh-eating microbes. Isr J Med Sci (1996) 0.75
Bacterial laryngotracheitis associated with toxic shock syndrome in an adult. Clin Infect Dis (1994) 0.75
Improving implementation of infection control guidelines to reduce nosocomial infection rates: pioneering the report card. J Hosp Infect (2012) 0.75
Antimicrobial resistance patterns among urine isolates from patients in a geriatric hospital and from older patients in a general hospital in Jerusalem. J Am Med Dir Assoc (2003) 0.75
Plantar ulcers and eyebrow-hair paucity. Clin Infect Dis (2006) 0.75
Septate-tubular textures in 2.0-Ga pillow lavas from the Pechenga Greenstone Belt: a nano-spectroscopic approach to investigate their biogenicity. Geobiology (2010) 0.75
[Bacterial toxins that affect host cAMP metabolism]. Harefuah (1985) 0.75
Clostridium septicum bacteremia and diffuse spreading cellulitis of the head and neck in a leukemic patient. Rev Infect Dis (1991) 0.75
Eighty thousand beta-adrenoreceptors in a single cell. Nature (1977) 0.75
Interaction of enteropathogenic Escherichia coli with host epithelial cells. Folia Microbiol (Praha) (1998) 0.75
[Group A streptococcal infections--from follicular tonsillitis to the "flesh-eating bacteria" syndrome]. Harefuah (1995) 0.75
Evaluating the laboratory techniques used in the diagnosis of sputum-producing-patients suspected of Mycobacterium infection. West Afr J Med (1998) 0.75
Seroepidemiology of human immunodeficiency virus infection in Borno State of Nigeria by sentinel surveillance. J Acquir Immune Defic Syndr (1993) 0.75
Cellulitis in a post-kidney transplant patient--more than meets the eye. QJM (2010) 0.75